Application of dandelion polysaccharides in preparation of drugs for inhibiting angiogenesis of hepatocellular carcinoma cells
A technology for inhibiting liver cancer and angiogenesis, applied in the field of medicine, can solve the problem of not inhibiting the blood vessels of liver cancer cells, and achieve the effect of inhibiting tumor angiogenesis and broad application prospects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The invention relates to the application of dandelion polysaccharide in the preparation of drugs for inhibiting angiogenesis of liver cancer cells. The present invention also provides that the liver cancer includes human liver cancer HepG2 cells, human umbilical vein endothelial cells HUVEC, and mouse liver cancer cells H22. The drug for inhibiting angiogenesis of liver cancer cells can inhibit the migration of human umbilical vein endothelial cells HUVEC. The drug for inhibiting angiogenesis of liver cancer cells can inhibit the formation of human umbilical vein endothelial cells HUVEC blood vessel. The drug for inhibiting angiogenesis of liver cancer cells can inhibit the formation of blood vessels in subcutaneous tumor tissue of mouse liver cancer cells H22. The drug for inhibiting angiogenesis of liver cancer cells can inhibit the expression of VEGF and VEGFR genes in human liver cancer HepG2 cells. The drug for inhibiting angiogenesis of liver cancer cells can in...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com